Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma

  • Authors:
    • Jong‑Shiaw Jin
    • Lien‑Fu Lin
    • Jui‑Chang Chen
    • Chia‑Chi Huang
    • Jeng‑Horng Sheu
    • Wenlung Chen
    • Tang‑Yi Tsao
    • Chih‑Wei Hsu
  • View Affiliations

  • Published online on: September 25, 2015     https://doi.org/10.3892/ol.2015.3749
  • Pages: 3712-3718
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The expression of cyclin A, B1, D1 and E in gastric adenocarcinoma is known to be associated with clinical outcome. However, few studies have investigated the role of cyclin T1 and cyclin‑dependent kinase 9 (CDK9) in gastric adenocarcinoma. Therefore, this study assessed the clinical significance of cyclin T1 and CDK9 expression in gastric adenocarcinoma. A total of 39 gastric adenocarcinoma patients received either radical total or distal gastrectomy in this study. Surgical tissue slides were stained with CDK9 and cyclin T1 antibodies, and immunohistochemistry scores and disease‑free survival (DFS) rates were analyzed. Among the 19 patients with tumor‑recurrent or distant metastasis, 16 were recorded as exhibiting low expression of cyclin T1. The remaining three patients exhibited high expression of the antibody. The results of patients with a higher T stage, N stage and tumor grade were less favorable. For patients with adenocarcinoma, the percentage of tissue slides stained with cyclin T1 was significantly higher than for those with normal stomach epithelia. The DFS rates of patients with low expression of cyclin T1 were significantly associated with poorer DFS rates. In conclusion, high expression of cyclin T1 is a favorable prognostic factor in treating patients with stomach adenocarcinoma.
View Figures
View References

Related Articles

Journal Cover

December-2015
Volume 10 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jin JS, Lin LF, Chen JC, Huang CC, Sheu JH, Chen W, Tsao TY and Hsu CW: Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma. Oncol Lett 10: 3712-3718, 2015.
APA
Jin, J., Lin, L., Chen, J., Huang, C., Sheu, J., Chen, W. ... Hsu, C. (2015). Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma. Oncology Letters, 10, 3712-3718. https://doi.org/10.3892/ol.2015.3749
MLA
Jin, J., Lin, L., Chen, J., Huang, C., Sheu, J., Chen, W., Tsao, T., Hsu, C."Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma". Oncology Letters 10.6 (2015): 3712-3718.
Chicago
Jin, J., Lin, L., Chen, J., Huang, C., Sheu, J., Chen, W., Tsao, T., Hsu, C."Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma". Oncology Letters 10, no. 6 (2015): 3712-3718. https://doi.org/10.3892/ol.2015.3749